Dr. Serhat Gümrükçü’s candidate for corona drug was announced

Within the scope of the research, the clinical results of which were announced at the international conference called Retroviruses and Opportunistic Infections, FDA approval was applied for the trial on humans. After the method is successful on humans, it is aimed to be used both as a therapeutic and preventive by spraying the drug into the mouth once at intervals such as 9-10 months. In addition, with this method, it is aimed to prevent SARS-CoV-1, SARS viruses that will mutate, and outbreaks caused by corona virus. Serhat Gümrükçü said that his research focuses on destroying the new type of corona virus using its components. Explaining the working mechanism of the treatment method called Hijack RNA, Gümrükçü gave the following information:

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.